Aclaris Therapeutics Overview
Aclaris Therapeutics Target Price
Analysts' 12-month price predictions for ACRS.
Get informed when a big investor buys or sells
+ FollowShare Price
$5.56
Average Target Price
$10.75
93.3% upside
93.3% upside4 analysts in the last 4 months
High: $12 | Low: $10
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-05 | Piper SandlerBiren Amin | $11 | 97.8% upside |  |
| 2026-05-05 | Guggenheim | $12 | 115.8% upside | |
| 2026-04-29 | WedbushMartin Fan | $10 | 79.9% upside | |
| 2026-04-16 | UBS | $10 | 79.9% upside | |
| 2026-01-30 | Craig-HallumAdam Vogel | $10 | 79.9% upside | |
| 2024-11-19 | BTIGJulian Harrison | $8 | 43.9% upside | |
| 2024-11-19 | JefferiesRoger Song | $7 | 25.9% upside | |
| 2024-11-06 | Stifel NicolausAlex Thompson | $3 |  46% downside | |
| 2022-12-01 | Goldman Sachs | $25 | 349.6% upside | |